| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |